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Abstract
The Supreme Court’s 1993 decision in Daubert v. Merrell Dow
Pharmaceuticals transformed courts’ evaluation of expert testimony.
Many courts, applying Daubert, focus extensively on whether the
purported expert’s methodology has been published in a peer-reviewed
journal.
This focus on peer review results in two unintended
consequences that have triggered criticism: litigation-driven
scholarship and litigants taking discovery into the peer review process.
Critics contend that litigation-driven scholarship is irredeemably
biased and that peer review discovery is too often an effort to
intimidate scholars from speaking on subjects of public concern.
In this Article, I explore these phenomena and the criticisms of
them, as well as the history of peer review itself. Contrary to the
critics, I ultimately conclude that each, in fact, can strengthen both law
and science through cross-fertilization, if appropriate checks are
established. Such efforts will better reflect law and science’s
overlapping magisteria (a term roughly meaning the disciplines’ area
of authority). A better recognition and understanding of this overlap
will create incentives to improve both law and science.
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“Science” plays a central role in litigation today. Civil litigants spend hours
briefing and arguing the value of expert testimony. Studies performed years
previously are taken apart and evaluated in detail. Criminal defendants are
convicted or exonerated based on DNA evidence. And all of the evidence comes in
through expert testimony – from witnesses who seek to explain the scientific issues
to a lay jury, often in the form of opinion testimony.1 This testimony can, and often
does, dictate the outcome of cases.
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Courts wrestle with the admissibility and use of scientific evidence every day,
and have developed an evolving set of standards to apply to those decisions,
seeking, at least in part, to have legal factfinders consider only evidence that has
already been deemed reliable in science – in other words, to have law follow science.
The most recent iteration of the standards adopted to further those goals started, of
course, with Daubert.2 With that case and throughout the cases that followed,
courts have sought to use science’s paradigms of “reliability” as the standards of
admissibility. If the scientific community has approved of the methods or
conclusions (through peer-reviewed publication and other criteria), the courts
conclude that those methods or conclusions should be admitted. The courts (and
many commentators) believe that making legal standards track the perceived
scientific standards improves the quality of fact-finding – i.e., that scientists’
standards of reliability should be courts’ standards of reliability.
In making this Daubert shift – more closely linking admissibility to scientific
standards of reliability – the courts paid little attention, if any, to the potential
impact making such a shift could have on science itself, or how it could affect the
nature and quality of the scientific evidence being presented to fact-finders, most
typically a jury. In this Article, the first in a broader project in law and science, I
explore two unexpected consequences of joining science and law at the hip, and
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See Daubert v. Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993).
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consider whether these consequences represent reciprocal contamination, or instead
cross-fertilization, of law and science.3
In the first unexpected consequence, the reliance (perhaps over-reliance) on
peer-reviewed publication in admissibility decision-making has resulted in
aggressive litigation discovery into the peer review process. Documents from the
peer review process have been subpoenaed, and the participants in that process
have been deposed, all with an eye to undermining the perceived value of the peer
review process, and, possibly, to purposefully deter the future involvement in that
very process by researchers and reviewers. This discovery was described in one
instance as “’harassment to silence independent research’ and an effort to create ‘a
chilling effect on folks who tell the truth.’”4 Under this view, letting the lawyers
into the citadel of science in this way could weaken science’s ability to assist the
legal fact-finding process, and to assist society more generally, by creating
disincentives for scholars to participate in the peer review process or to be fully
honest in that process. These disincentives may be created whether or not the
litigants intend them.
In the second unexpected consequence, the focus on following science’s
paradigms (again most notably peer review) has resulted in what can be called
“litigation-driven scholarship.” Some expert witnesses have performed litigation-

3

By “cross-fertilization” I refer to the agricultural concept (also called allogamy) of crossing a male
from one species and a female from another. In the same way that crossing gametes in plants can
create a disease-resistant plant or crossing an Angus bull with a Hereford cow can result in a fastergrowing calf than a purebred calf of either species, I argue below that the interchange between law
and science can strengthen both.
4 Jon Wiener, “Cancer, Chemicals and History,” The Nation (Feb. 7, 2005).
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related research and essentially submitted their expert reports to peer-reviewed
journals in what appears to be, at least in part, an attempt to bolster the likelihood
of their testimony being admitted.5 These efforts may cheapen the value of the
paradigmatic reliability indicators in science and decrease the quality of scholarship
presented to fact-finders (and to consumers of scholarship), reversing one core idea
of the shift – that law should follow science, rather than the reverse. At the least,
many observers find such scholarship unseemly if not outright untrustworthy, due
to the obvious potential for bias.
This Article explores what I argue was and remains inevitable: the conflicts
growing out of the overlapping magisteria6 of law and science, driven by the
attempt to join them together. I conclude that it is far from self-evident that the
“contamination” of science by law (e.g., lawyers meddling in peer review) or of law
by science (e.g., litigation-driven scholarship showing up in litigation) necessarily
weakens either science or law. Instead, they may serve as a check on each other
and on other potential problems.
In fact, the reciprocal line-crossing – of litigators into the peer-review process,
and of litigation experts into the peer-reviewed scholarship– may make both law

5

Conversely, and importantly, some researchers who first become scholars on a subject later are
recruited as litigation experts. Of course, the lag time between research being completed and the
review and publication process being completed can undermine either effort, but, especially in major
litigation, the lag is not so great as to preclude it. See infra note 103 and accompanying text.
6 “Magisteria” is a term for the teaching authority of a particular area of inquiry – “a word derived
not from any concept of majesty or awe but from the different notion of teaching, for magister is
Latin for ‘teacher.’” Steven Jay Gould, “Nonoverlapping Magisteria,” at
http://www.stephenjaygould.org/library/gould_noma.html (1997). One can think of magisteria as
areas of authority – the relevant subject areas of disciplines. Gould used the term in an essay about
the purported conflicts between evolution and religious belief, concluding that religion and science
need not have overlapping magisteria and thus that religion and science can coexist. See id.
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and science stronger and provide a better understanding of both. A complete
understanding and exploration of the peer review process by litigants and the court
would, in other words, improve both law and science. Thus, rather than
contamination, such interactions should be considered as cross-fertilization,
strengthening both. The complex interplay between these overlapping and
competing magisteria may cause discomfort and (hopefully transient) confusion, but
it should be cautiously welcomed, not avoided.
I proceed in four parts. First, I provide a brief review of the evolution of legal
standards for the admissibility of what is termed “scientific evidence,” including
Frye and Daubert and their progeny. I also explore the stated and unstated goals of
the shift from Frye’s focus on the “general acceptance” of the expert’s approach to
Daubert’s emphasis on the reliability and relevancy of the expert’s methodology.
Second, I give a (necessarily limited) overview of certain modern scientific
paradigms of reliability. In this Part, I explore the realities of peer review7 and of
other institutions in science that are relied upon in evidentiary determinations.
Among other things, I explore the history of peer review in science and establish
that only relatively recently did peer review become a central aspect of general
scientific scholarship. In this Part, I conclude that the factors judges and litigators
7

Here, and throughout the article, I focus on editorial peer review – that is, the review that takes
place as part of publication decisions. The ongoing evaluation of scientific research by others,
publications of challenging counterpoints, and so on all constitute what some commentators identify
as “true peer review.” See Effie J. Chan, Note, The “Brave New World” of Daubert: True Peer Review,
Editorial Peer Review, and Scientific Validity, 70 N.Y.U. L. Rev. 100 (1995). Some courts, too,
recognize this broader (and arguably more important) concept of peer review. See infra note 40.
Arguably, there are two levels of peer review prior to editorial peer review – what could be called
“local peer review” (intra- and inter-institutional informal discussions, for example) and “editor peer
review” (the first-cut determination by a journal editor). Daubert, however, put the focus on editorial
peer review and the phenomena I discuss are in that area as well.
6 of 57

Childs • Overlapping Magisteria

see as binary – e.g., either the method is peer reviewed or it is not – are not nearly
so simple to resolve. This Part, among other things, includes examples of exactly
what peer reviewers are asked to do from various journals, and it varies
significantly. Put more bluntly, there’s peer review, and then there’s peer review –
and even careful and thorough peer review can miss fraud, as recent high-profile
cases have shown. This conclusion will be important in evaluating whether the
unexpected consequences of Daubert are problematic.
Third, I describe two phenomena (summarized above) that are, to my
knowledge, relatively new – and almost certainly the direct result of the courts’
emphasis on peer review as a criterion for the admission of expert testimony. The
first phenomenon is discovery in litigation into the peer review process – document
and testimonial discovery exploring and challenging the peer review process with
an eye towards undermining the admissibility of testimony relying on the reviewed
publication. The prospect of being put through such discovery may create
incentives for scientists to refuse to participate in such a process; it may weaken the
honesty of the comments provided in that process; it may be used to intimidate
other potential experts; and it may impinge upon academic freedom. At the same
time, it may provide valuable and relevant evidence of the reliability of the methods
and conclusions in the publication and educate the courts about the nature of peer
review.
The second phenomenon discussed in the third Part is related: scholarship
that appears to be produced (and submitted to peer-reviewed publications), at least
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in part, to increase the odds of the authors’ opinions being admitted in litigation.
This bootstrapping may result in work that would not otherwise be published – and
perhaps should not be published. And indeed, some research motivated by
litigation may never be performed at all in the absence of litigation. Research may
be published too soon (or sooner than it otherwise would have been) because the
litigation schedule associated with the research is more time-pressured than the
scientific community’s. Science works incrementally; lawyers (especially those on a
contingent fee) have every reason to work fast – statutes of limitations, the time
value of money, and the ethical obligation to represent one’s client zealously all
work together to make a litigation timeline much shorter than a pure research
timeline might be. This incentive to create scholarship may result in the
publication of whole new areas of purported expertise that have not previously been
published and that may not genuinely be properly the subject of expert testimony –
scientists opining about the ethics of defendants, for example.
Finally, I explore the likely ultimate consequences of the development of
discovery into peer review and litigation-driven scholarship and conclude that they
are not so bad, after all. The phenomena are especially acceptable if they both
occur, as they work to balance each other – though I do not limit my conclusions to
the situation in which both take place.
As for litigants taking discovery into the peer review process, what is meant
by “peer review” varies widely, and it is sensible to permit litigants to explore the
quality of the peer review involved when its conclusions are being used against
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them. That process will better educate the courts about how much reliance to place
on peer review as an indicator for reliability, much in the way that Daubert has
educated judges about science and its methods more generally. Further, discovery
into peer review can provide a rough analogue to what is called post-publication
peer review, and that can only help, rather than hurt, the continued development of
reliable knowledge in both science and law. The concerns about disincentives to
participants in that process are, while not trivial, relatively minor and can be
mitigated relatively inexpensively and without undercutting the critical features of
peer-reviewed scholarship. My conclusions are strongest in the context where the
peer-reviewed author is acting as a litigation expert, but are not limited to that
context.
Similarly, while there is something unseemly about articles published by
litigation experts with an intention to assist the litigants, there are sufficient
gatekeepers in place to conclude that such scholarship is not inherently bad.8
Between peer review itself, strong disclosure requirements (which I contend should
be made stronger, including a requirement that litigation-driven scholarship
authors disclose their payments for litigation work), and the availability of
discovery into the process, the potential negative impact of that scholarship is
minimized. Further, the resources that litigants can bring to bear – especially in

8

And the unseemliness may be no greater than when the research is performed specifically to
support the approval and marketing of a drug, for instance. That said, my perception is that most
attorneys and scientists are more uncomfortable with litigation-driven scholarship than with, for
example, clinical trials sponsored by a drug maker, though that discomfort may be a function of a
lack of familiarity. While research for approval or marketing purposes has existed for years,
litigation-driven scholarship is clearly newer.
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mass tort cases, which for economic reasons are the sort of cases where these events
tend to arise – may result in important research being performed that otherwise
would be performed later or never. The fact that litigants are funding such work is
undoubtedly important in its evaluation (and, again, mitigates in favor of
permitting discovery into the publication process), but that fact should not, by itself,
make the scholarship either unpublishable in journals or inadmissible in court,
especially when comparable bias is present in many articles that are admitted
without a fight.
I. From Frye to Daubert and Kumho Tire and Beyond: A Focus on
Methods, Not Qualifications
It is nearly automatic for lawyers, judges, and commentators to blurt out
“gatekeeper!” any time Daubert is mentioned. Indeed, the case emphasizes the
importance of judges preventing unreliable expert testimony from being heard by
the jury, and has by most accounts increased the scrutiny given to proffered expert
testimony.9
Prior to Daubert (and in most states in which Daubert or its equivalent has
not been adopted), the nominal standard was Frye v. United States.10 Frye, taking
up less than two pages in the Federal Reporter, evaluated the admissibility (in a
criminal trial) of expert testimony regarding an early lie detector test. The court,

9

See, e.g., Rudlin, The Judge as Gatekeeper: What Hath Dauberg-Joiner-Kumho Wrought?, 29 PROD.
SAF. & LIAB. REPO. 329 (BNA Apr. 2, 2001). This more exacting examination has occurred despite
the Court’s references to the opinion reflecting a “liberalizing” of standards. See infra note 14 and
accompanying text.
10 See Frye v. United States, 293 F. 1013 (D.C. Cir. 1923).
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after briefly summarizing the theory underlying the test,11 concluded that
testimony based on that theory could not be admitted:
Just when a scientific principle or discovery crosses the
line between the experimental and demonstrable stages is
difficult to define. Somewhere in this twilight zone the
evidential force of the principle must be recognized, and
while courts will go a long way in admitting expert
testimony deduced from a well-recognized scientific
principle or discovery, the thing from which the deduction
is made must be sufficiently established to have gained
general acceptance in the particular field in which it
belongs.12
Thus, Frye’s focus is on the expert’s field of inquiry and the theory on which
the expert purports to rely, along with the basic requirement that the expert be
generally qualified to speak about the subject.
In 1993, the Supreme Court considered the proper restrictions on expert
testimony given the adoption of the Federal Rules of Evidence, concluding first that
the Rules superseded Frye.13 In reaching that conclusion, the Court noted that
Frye’s “rigid ‘general acceptance’ requirement would be at odds with the ‘liberal
thrust’ of the Federal Rules and their ‘general approach of relaxing the traditional
barriers to ‘opinion’ testimony.’”14 Parsing the language of Rule 702, the Court
concluded that the expert’s testimony must be “scientific” and relate to “scientific

11

“[T]he theory seems to be that truth is spontaneous, and comes without conscious effort, while the
utterance of a falsehood requires a conscious effort, which is reflected in the blood pressure.” Id. at
1014.
12 Id. (emphasis added).
13 See Daubert v. Merrell Dow Pharmaceuticals, 509 U.S. 583, 585-89 (1993).
14 Id. at 588 (quoting Beech Aircraft Corp. v. Rainey, 488 U.S. 153, 169 (1988)).
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knowledge,” which “implies a grounding in the methods and procedures of science”
and “connotes more than subjective belief or unsupported speculation.”15
Based on that interpretation of the Rule, Daubert focuses trial courts more
precisely on the expert’s methodology rather than the acceptance of the expert’s
more general field of work.16 Most important for purposes of this Article, Daubert
enumerates non-exclusive criteria for consideration – testability,17 peer review,18
error rate,19 control standards, and (echoing Frye) general acceptance.20 These
factors were drawn in large part from an effort to define “scientific” in the ways that
the Court believed scientists did.21
The post-Daubert amendment to Rule 702 and its official comments expressly
incorporated those criteria and added several more – whether the expert’s work is
litigation-specific, whether the expert is unjustifiably extrapolating to an improper
conclusion, whether the expert has accounted for alternative explanations, whether
the expert’s work is as cautious in litigation as it would be in ordinary work, and
whether the expert’s claimed field of expertise is known for reaching reliable

15

Id. at 589-90. The case also addresses further the issues of qualification and fit, but those
discussions are not directly relevant to the subject of this Article.
16 See id. at 592-93.
17 “Ordinarily, a key question to be answered in determining whether a theory or technique is
scientific knowledge that will assist the trier of fact will be whether it can be (and has been) tested.”
Id. at 593.
18 “The fact of publication (or lack thereof) in a peer reviewed journal thus will be a relevant, though
not dispositive, consideration in assessing the scientific validity of a particular technique or
methodology on which an opinion is premised.” Id. at 594.
19 “[I]n the case of a particular scientific technique, the court ordinarily should consider the known or
potential rate of error . . . .” Id. at 594.
20 “Widespread acceptance can be an important factor in ruling particular evidence admissible, and ‘a
known technique which has been able to attract only minimal support within the community’ . . .
may properly be viewed with skepticism.” Id. at 594 (quoting United States v. Downing, 753 F.2d
1224, 1238 (3d Cir. 1985)).
21 See id. at 592-94.
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results.22 What “reliable” means in connection with methodology can vary, of course
– a proper method to measure the temperature of a liquid is presumably a fairly
precise question, while the proper method to evaluate the likelihood of user
confusion in the face of a particular drug label on a product may be more nebulous.
Since Daubert, the Supreme Court has established that the standard of
review of district court decisions is abuse of discretion23 and established that the
Daubert approach is to be used in all expert testimony evaluation, not just what
might traditionally be called “science.”24
Consider for a moment the criteria adopted by Daubert and described in the
comments to Rule 702, and take note of the wiggle room present in virtually all of
them:
•

Testability: “whether the expert’s technique or theory can be or has
been tested – that is, whether the expert’s theory can be challenged in
some objective sense, or whether it is instead simply a subjective,
conclusory approach that cannot reasonably be assessed for
reliability”25;

•

Peer review: “whether the technique or theory has been subjected to
peer review and publication”26;

•

Error rate: “the known or potential rate of error of the technique or
theory when applied”27;

22

See F. R. EVID. 702.
See General Electric v. Joiner, 522 U.S. 136 (1997).
24 See Kumho Tire Co. v. Carmichael, 526 U.S. 137 (1999).
25 Committee Notes on 2000 Amendment to F. R. Evid. 702.
26 Id.
23
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•

Control standards: “the existence and maintenance of standards and
controls”28;

•

General acceptance: “whether the technique or theory has been
generally accepted in the scientific community”29;

•

Litigation-based: “Whether experts are ‘proposing to testify about
matters growing naturally and directly out of research they have
conducted independent of the litigation, or whether they have
developed their opinions expressly for purposes of testifying’”30;

•

Extrapolation: “Whether the expert has unjustifiably extrapolated from
an accepted premise to an unfounded conclusion.”31

•

Alternative explanations: “Whether the expert has adequately
accounted for obvious alternative explanations.”32

•

Level of care: “Whether the expert ‘is being as careful as he would be in
his regular professional work outside his paid litigation consulting.’”33

•

Reliability of field: “Whether the field of expertise claimed by the
expert is known to reach reliable results for the type of opinion the
expert would give.”34

27

Id.
Id.
29 Id.
30 Id. (quoting Daubert v. Merrell Dow Pharmaceuticals, Inc., 43 F.3d 1311, 1317 (9th Cir. 1995).
31 Id. (citing General Elec. Co. v. Joiner, 522 U.S. 136, 146 (1997).
32 Id. (citing Claar v. Burlington N.R.R., 29 F.3d 499 (9th Cir. 1994).
33 Id. (quoting Sheehan v. Daily Racing Form, Inc., 104 F.3d 940, 942 (7th Cir. 1997)).
34 Id. (cit
ing Kumho Tire Co. v. Carmichael, 526 U.S. 137, 151 (1999)). This factor is relevant when
the purported discipline itself lacks reliability – for example, “astrology or necromancy.” Kumho Tire
at 151.
28
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The only one of the bunch that at least seems binary – i.e., it’s either there or
it is not – is peer review. Its presence can be determined with a single yes-or-no
question: “Has the methodology you are following been subjected to peer review?”
(And, as discussed below, if the expert can say, “Yes, and my conclusion on this very
issue has been peer reviewed too,” so much the better.) Given the apparent ease of
evaluating it as a factor, litigants and courts tend to focus on peer review – if not to
the exclusion of other factors, at least more heavily than Daubert and the drafters of
Rule 702 might have intended.35 Put another way, in considering the panoply of
criteria in play, courts might be expected to latch onto peer review as an easy one to
consider. And indeed, that is what has happened, at least in some cases.
One need go no further than the Ninth Circuit’s consideration of the
remanded Daubert case itself to see one of many examples of this sort of enthusiasm
for peer review. Discussing the scenario where the proposed testimony is not from
independent research, the court looked for “other objective, verifiable evidence that
the testimony is based on ‘scientifically valid principles.’” As an example of such
evidence, the Ninth Circuit suggested that
[o]ne means of showing this is by proof that the research
and analysis supporting the proffered conclusions have

35

The Daubert court itself was rather cautious in describing peer review’s value, which suggests that
courts that rely on peer review to the exclusion of other factors may do so contrary to the Court’s
intentions. “Publication (which is but one element of peer review) is not a sine qua non of
admissibility; it does not necessarily correlate with reliability, . . . and in some instances wellgrounded but innovative theories will not have been published . . . . Some propositions, moreover,
are too particular, too new, or of too limited interest to be published. But submission to the scrutiny
of the scientific community is a component of ‘good science,’ in part because it increases the
likelihood that substantive flaws in methodology will be detected.” Daubert, 509 U.S. 579, 593 (1993)
(citations omitted).
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been subjected to normal scientific scrutiny through peer
review and publication.36
The court then drops a footnote:
We refer, of course, to publication in a generallyrecognized scientific journal that conditions publication on
a bona fide process of peer review. . . .37
And continues:
Peer review and publication do not, of course, guarantee
that the conclusions reached are correct; much published
scientific research is greeted with intense skepticism and
is not borne out by further research. But the test under
Daubert is not the correctness of the expert’s conclusions
but the soundness of his methodology. That the research
is accepted for publication in a reputable scientific journal
after being subjected to the usual rigors of peer review is
a significant indication that it is taken seriously by other
scientists, i.e., that it meets at least the minimal criteria
of good science.38
36

Daubert II, 43 F.3d 1311, 1318.
Id. n. __.
38 Id. Similarly, the Northern District of Georgia has dismissed an unpublished study as having
“little probative value” because it was “not subject to peer review.” Smith v. Ortho Pharmaceutical
Corp., 770 F. Supp. 1561 (N.D. Ga. 1991); see also, e.g., Marsh v. W.R. Grace & Co., 80 Fed. Appx.
883, 887-88 (4th Cir. 2003) (“Peer review helps to ensure that research papers are scientifically
accurate, meet the standards of the scientific method, and are relevant to other scientists in the field
. . . . [P]eer review involves scientists submitting a manuscript to a scientific publication in the field,
journal editors soliciting critical reviews from other experts in the field and deciding whether the
scientist has [generally] employed sound science.”); Brock v. Merrell Dow, 874 F.2d 307, 313 (5th Cir.
1989) (“While we do not hold that this failure [to be peer reviewed], in and of itself, renders his
conclusions inadmissible, courts must nonetheless be especially skeptical of medical and other
scientific evidence that has not been subjected to thorough peer review.”).
Certainly many courts understand the complexity of peer review and recognize that
publication peer review is far from a guarantee – or even necessarily a particularly strong indication
– of reliability of either methodology or result, possibly to an extreme. See, e.g., Valentine v. Pioneer
Chlor Alkali Co., Inc., 921 F. Supp. 666 (D. Nev. 1996) (minimizing the value of editorial peer
review); State v. O'Key, 321 Ore. 285, 304 (Or. 1995) (noting limitations of peer review). As to those
courts, my later focus on the education of judges is presumably less relevant. But those courts, too,
will be already more interested in the specific type of peer review with which they are faced, and
thus less automatically skeptical of efforts to obtain discovery into the peer review process.
While it is beyond the scope of this Article, significant parallels exist between the
phenomenon in the context of litigation and similar incentives and responses in regulatory contexts,
in particular in connection with the Endangered Species Act’s requirement that conclusions be based
on the “best scientific. . . information available.” This requirement has led to a strong preference for
peer reviewed work and thus, predictability, scholarship designed to satisfy that very requirement.
37
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Whether or not the Court or the Advisory Committee intended it, then, peer
review has become a central part of expert evaluation. Because of that centrality,
litigants have done what we might have expected, and some of those actions make
lawyers and scientists uncomfortable. Before addressing those consequences and
the discomfort, though, a discussion of peer review as an indicator of scientific
reliability is appropriate.
II.

The Realities of Peer Review

Judging from many judicial discussions of peer review, one could be forgiven
for thinking that peer review dated to the earliest development of science, and that
perhaps peer reviewers were excommunicated along with Galileo for approving the
publication of his thoughts about the shape of the planet. But in fact, peer review
in its current form is a relatively new concept and it is far from infallible.
Though peer review probably started in the mid-1700s,39 as recently as the
1950s, peer review was part of publishing in only some journals in some
disciplines.40 Thus, for example, Crick and Watson’s seminal article in Nature on
the structure of DNA was not peer reviewed, not because (as various stories tell it)
they did not want to tip off other researchers (in particular Linus Pauling) or
because there was nobody competent to review it, but instead because Nature –
then as now one of a handful of the undisputed leading journals in the world –

39

See David A. Kronick, Peer Review in 18th-Century Scientific Journalism, 263 JAMA 1321 (1990).
See Effie J. Chan, Note, The “Brave New World” of Daubert: True Peer Review, Editorial Peer
Review, and Scientific Validity, 70 N.Y.U. L. Rev. 100, 116 (1995).
40
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simply had no peer review process. As described in an annotation to a reprint of the
paper:
Nature (founded in 1869)—and hundreds of other
scientific journals—help push science forward by
providing a venue for researchers to publish and debate
findings. Today, journals also validate the quality of this
research through a rigorous evaluation called peer review.
Generally at least two scientists, selected by the journal’s
editors, judge the quality and originality of each paper,
recommending whether or not it should be published.
Science publishing was a different game when Watson
and Crick submitted this paper to Nature. With no formal
review process at most journals, editors usually reached
their own decisions on submissions, seeking advice
informally only when they were unfamiliar with a
subject.41
Today, the peer review process varies widely. The most common form is as
described above – two (or more) reviewers in a relevant field reviewing the article
and advising the editors as to its value.42 Of course, the reviewers do not
themselves perform the experiments or primary research to confirm its results, nor
do they ordinarily access the underlying data – the data presented are rarely the
raw data; they have long since been analyzed.43 They instead accept the data as
presented by the authors and that the methods used matched the methods
described, and decide whether the conclusions reached are appropriate and

41

http://www.exploratorium.edu/origins/coldspring/ideas/printit.html
See Chan, supra note 40.
43 See Chan, supra note 40, at 120.
42
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interesting in the relevant discipline, and whether the methods described were
appropriate.44
Sometimes the process varies. In a case explored in litigation (and described
in more detail below), the reviewers were not anonymous (indeed, some were from
one author’s institution), and the review process took place in a room with the
authors present and an active part of the discussion.45 Such an approach is likely
more common when the publisher has all but decided to publish th
e book and is
using the peer review process as more of an editing process than a selection process.
In a handful of cases, journals have begun to use “open peer review,” where
both the identity of the reviewers and the substance of their comments are open –
not just to the authors but to everyone.46 This has the potential of mitigating
biases, incentivizing thorough review, and reducing the possibility of discovery into
the peer review process discussed below.
Occasionally – possibly even frequently – authors suggest potential
reviewers. Especially in particularly specialized subject matters, this may be a
necessity in order to find qualified reviewers. Even if the authors do not suggest

44

See infra note 51 and accompanying text for a more detailed discussion of questions asked in the
peer review process by some journals.
45 See infra note 74 and accompanying text. This review process, as noted in the text, involved a
book rather than an article, where the review process might properly differ; nonetheless, an opposing
expert stated that it was unusual even in that context.
46 See, e.g., http://www.biology-direct.com/info/about/ (“Biology Direct's key aim is to provide authors
and readers of research articles with an alternative to the traditional model of peer review. This
includes making the author responsible for obtaining reviewers' reports via the journal's Editorial
Board; making the peer review process open rather than anonymous; and making the reviewers'
reports public, thus increasing the responsibility of the referees and eliminating sources of abuse in
the refereeing process.”). Open peer review would be an option available to journals that seek to
avoid discovery into the peer review process. See infra __.
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reviewers, the fields may be so small that the author can guess with some accuracy
who is doing the review.
No matter the structure of the process, the realities of the review itself can
vary widely as well. Peer reviewers are typically active researchers themselves
with limited time. One article might receive an hour of review, while another might
receive days.47
The reviewers themselves may have agendas in the field (simply by being
active), and may well have a financial interest affected by the work.48 With a
growing proportion of research being privately-funded, the odds of finding an
entirely disinterested researcher – especially in narrow subject matters – may be
slim. Even if the reviewer’s interest is simply a disinclination to endorse an article
that questions a view the reviewer has previously held, rather than a financial
stake, it still presents potential bias.49 And of course, the reviewer may perceive the

47

Two studies indicate that the average is probably around two to three hours. See Alfred Yankauer,
Who Are the Peer Reviewers and How Much Do They Review?, 263 JAMA 1338, 1339 (1990); Stephen
Lock & Jane Smith, What do Peer Reviewers Do?, 263 JAMA 1341, 1342 (1990).
48 The interest could be based on a desire for ongoing grants or future employment as a clinical trial
investigator, for example. See, e.g., International Committee of Medical Journal Editors, Uniform
Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for
Biomedical Publication (http://www.icmje.org/#conflicts):
The potential for conflict of interest can exist whether or not an individual believes
that the relationship affects his or her scientific judgment. Financial relationships
(such as employment, consultancies, stock ownership, honoraria, paid expert
testimony) are the most easily identifiable conflicts of interest and the most likely to
undermine the credibility of the journal, the authors, and of science itself. However,
conflicts can occur for other reasons, such as personal relationships, academic
competition, and intellectual passion.
49 Such bias may, in fact, still be financial, but indirectly so, with concerns about challenges to the
reviewer’s views reducing available funding.
20 of 57

Childs • Overlapping Magisteria

author as a competitor for funding even if the author’s view is consistent with the
reviewer’s, so bias may exist whether or not the author and the reviewer agree.50
Precisely what a reviewer is asked to do varies by journal. The Journal of the
American Medical Association (JAMA), for example, categorizes comments into
seven areas of interest: “(1) Decision; (2) Priority; (3) Specific questions about the
manuscript's quality; (4) Manuscript background information; (5) Remarks to the
editor; (6) Remarks to the author; and (7) Conflict of interest statement for [the
reviewer].”51 JAMA further cites another paper for advice to reviewers, which
suggests, among other things, that the reviewer
should pay close attention to the methods section and
understand what the authors did. Does the study follow a
known study design? Did the authors follow the principles
of this design? If you have specific references on methods
or design that you think the authors should include, it is
tremendously helpful to provide that information.52
Nature instructs its reviewers (called referees) with the following primary
instructions:
The ideal review should answer the following questions:
Who will be interested in the paper, and why?
What are the major claims of the paper and how
significant are they?
How does the paper stand out in its field?
Are the claims novel and convincing? If not, which
published papers compromise novelty and what
further evidence is needed?

50

See id.
http://manuscripts.jama.com/cgi-bin/main.plex?form_type=display_rev_instructions (last visited
March 21, 2006).
52 Peter Cummings, et al., Reviewing Manuscripts for Archives of Pediatrics & Adolescent Medicine,
156 ARCH. PEDIATR. ADOLESC. MED. 11-13 (2002).
51
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Are there other experiments or work that would
strengthen the paper further?
How much would further work improve it, and how
difficult would this be? Would it take a long time?
Are the claims appropriately discussed in the context
of previous literature?
If the manuscript is unacceptable, is the study
promising enough to ask for a resubmission?53
The instructions continue:
If time is available, it is extremely helpful to the editors if
referees can advise on the following points:
Is the manuscript clearly written? If not, how could it
be made more accessible to nonspecialists?
Would readers outside the discipline benefit from an
online schematic of the main result?
Could the manuscript be shortened?
Should the authors be asked to provide supplementary
methods or data online?
Have the authors done themselves justice without
overselling their claims?
Have they been fair in treating previous literature?
Have they provided sufficient methodological detail
that the experiments could be reproduced?
Is the statistical analysis of the data sound, and does it
conform to the journal's guidelines?
Are the reagents generally available?
Are there any ethical concerns arising from the use of
human or other animal subjects?54
Note that the reviewers are expressly requested to discuss methodology only
in the secondary, “[i]f time is available,” set of questions. Presumably, of course,
their editorial board can evaluate methodologies to some extent, especially given
their background.55 Further, problems with methodology could likely come through
in response to some of the first set of questions, in particular in a discussion of
53

NATURE Information for Referees (on file with author).
Id.
55 See http://www.nature.com/nature/about/editors/index.html (last visited March 12, 2006).
54

22 of 57

Childs • Overlapping Magisteria

whether the paper is convincing. But the relegation of methodology, at least
expressly, to a second-tier question may be relevant to evaluating how well peer
review can be used to evaluate a methodology for Daubert purposes.
The range of activities – all of which can accurately be called “peer review” –
is such that entire conferences have taken place just about peer review.56 According
to some commentators,
There are thousands of scientific and medical journals in
the world . . . and many cannot fill their pages. The
resulting seller’s market means that a researcher can
publish even an inadequate article somewhere. Serious
and adequate publication peer reviewe remains relatively
rare. Even adequate publication peer review is
sometimes limited in that the review may involve only
one or two peer reviewers, and even the best reviewers
can only identify gross errors in methodology or
conclusions.57
All of this means, of course, that peer review is not a unitary concept, and it
is not a universally reliable proxy for reliability – the fact that an article is peerreviewed is not remotely the final word on its accuracy and reliability.58 One need
go no further than recent headlines for evidence of this, as in the case of the Korean
stem-cell researcher who published his work in none other than Science – work that

56

See, e.g., http://www.ama-assn.org/public/peer/prc_program2001.htm (last visited March 7, 2006).
Extensive scholarship exists on the range of peer review, and I have merely attempted to summarize
it. For a lengthier and more detailed summary, see, for example, William L. Anderson, et al.,
Daubert’s Backwash: Litigation-Generated Science, 34 U. MICH. J.L. REFORM 619, 624 (2001)
(hereafter “Daubert’s Backwash”).
57 See Daubert’s Backwash: Litigation-Generated Science, 34 U. MICH. J.L. REFORM 619, 624 (2001)
(hereafter “Daubert’s Backwash”).
58 See Chan, supra note 40, at 127-29 (summarizing misconceptions about the reliability of
conclusions published in peer-reviewed journals).
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turned out to be fraudulent.59 When the stakes are high, as in cutting
- edge
research with millions of research dollars at stake or in drug development where a
negative study might stop development of a potential blockbuster medicine, the
incentives are commensurately high for researchers to push the limits of accuracy
in providing data, and peer reviewers may be unable or unwilling to test the
assertions in a publication, and in fact are, by necessity, unable to evaluate
underlying data.
III. The Rationality of Litigants and Experts
So far, we have seen two important facts about peer review: First, courts like
it as a hook to rely upon in making decisions about the reliability (and thus
admissibility) of expert testimony, and second, its reality varies tremendously.
These two facts create opportunities for litigants discussed in this Part–
opportunities that have been taken by unsurprisingly rational and zealous
advocates.
First, it makes the litigants want, in some circumstances, to undercut the
probative value of the fact of peer review, which, in the context of litigation, means
taking discovery and calling witnesses at trial. Litigants have subpoenaed and will
continue to subpoena documents, not just from the litigation experts, but also from
publications relied upon and the reviewers involved in the peer review process.
They also have deposed and will continue to depose those involved with the process,
including editors and reviewers.
59

See Gina Kolata, Amid Confusion, Journal Retracts Korean's Stem Cell Paper, N.Y. TIMES (Dec.
31, 2005); Nicholas Wade, Clone Scientist Relied on Peers and Korean Pride, N.Y. TIMES (Dec. 25,
2005).
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Second, it makes litigants seeking to admit expert testimony – especially
expert testimony likely to be challenged as unreliable or novel – want to improve
their chances by converting litigation research into peer-reviewed published
research. I refer to this effort as “litigation-driven scholarship.” As noted above,
when an expert can cite not just a peer-reviewed article using the methodology in
question but also to a peer-reviewed article reaching the very conclusions to which
he proposes to testify, courts are likely to place some weight on that fact.
Both of these actions have engendered discomfort in both the scientific
community and the courts along the lines of that described, in a different context, in
a carpal tunnel syndrome products liability suit against keyboard manufacturers in
New Jersey:
Science coexists uneasily with litigation's adversary
system, as the imperatives of partisan advocacy coupled
with powerful economic incentives often seem to
overwhelm good science. Lawyers, judges, and forensic
experts sometimes engage in what literature teachers call
willing suspension of disbelief. Scientific propositions that
would cause even laymen to gasp in disbelief are routinely
argued in courts of law. Such are the dangers of a legal
system allowing partisan expert testimony.60
Before addressing that discomfort, let us explore exactly what is happening.

60

Reiff v. Convergent Technologies, 957 F. Supp. 573, 584 (D.N.J. 1997). Judge Irenas went on:
“Almost a century ago, when the use of hired-gun scientific witnesses was less common and on
shakier evidentiary grounds, Judge-to-be Learned Hand deplored the growing trend towards the use
of partisan scientific opinion testimony, deeming it an ‘evil in the present system.’ Id. (quoting
Learned Hand, Historical and Practical Considerations Regarding Expert Testimony, 15 HARV. L.
REV. 40, 55 (1901). Obviously, the propriety of partisan experts is well beyond the scope of this
Article, but the discomfort with that concept is similar to the discomfort with the phenomena
discussed herein.
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A. Peering Behind the Peer Review Curtain: Taking Discovery
What do I mean when I write of discovery into the peer review process? It
can take a number of forms, and in this sub-Part, I provide representative
examples, starting with one that has received a fair amount of attention.
In the mid 1990s, a plaintiff’s attorney in Louisiana contacted two wellcredentialed historians, Gerald Markowitz of the City University of New York and
David Rosner of Columbia University’s Mailman School of Public Health regarding
the vinyl chloride monomer industry.61 Vinyl chloride is a product used in the
production of, among other things, pipes and hoses.62 At one point, plaintiffs’
attorneys thought it might have the potential of being the basis for a massive mass
tort. To date, however, litigation has focused not on the end users but on
individuals in the manufacturing process who develop a particular liver cancer.63
An employee with that ailment retained the attorney who hired the
historians.64 In discovery, the defendants (representing a substantial portion of the
industry) had produced hundreds of thousands of pages of documents, and the
historians were initially asked to act as consulting experts in order to create a
chronology of industry knowledge.65 Their work was primarily focused on the
activities of an industry group and not on any particular company. The historians
concluded that the companies conspired to hide the dangers of the products.66

61

See Alexander Lane, Tempestuous Times in the Ivory Tower, STAR-LEDGER, Dec. 5, 2004 at 1.
See id.
63 See id.
64 See id.
65 See id.
66 See id.
62
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The historians’ research led to two relevant work products. The first was a
largely well-regarded book, Deceit and Denial: The Deadly Politics of Industrial
Pollution, published by the University of California Press and the Milbank Fund.67
The book explored the lead and vinyl chloride industries. The book particularly
explores industry knowledge of dangers of the product and its manufacturing
process, and the industry’s response (or lack thereof) to those dangers. One chapter
particularly focuses on the vinyl chloride industry. As noted above, the authors
concluded that the industry possessed but conspired to cover up material evidence
regarding the dangers of its product. The material in the book relating to the vinyl
chloride industry was based largely, if not entirely, on documents reviewed as the
historians’ work as paid consulting experts.68
The second work product was an expert report (over only Professor
Markowitz’s signature) provided to the plaintiffs’ attorneys in anticipation of
deposition and trial testimony:
I have been asked to review the history of the vinyl
chloride industry to understand and analyze what they
[sic] discovered about the health hazards of vinyl chloride,
67

See Gerald Markowitz and David Rosner, Deceit and Denial: The Deadly Politics of Industrial
Pollution (2002). For a selection of reviews, see http://www.deceitanddenial.org/reviews/ (last visited
March 12, 2006).
68 As I note below, this work could potentially be classified as “litigation-driven scholarship” as well
as being an example of discovery into the peer review process. It is not clear, however, that the
historians’ scholarly work was produced with an eye to litigation; at the time of the book’s writing, it
is possible that the authors were only retained as consulting witnesses. Additionally, there are
significant questions about whether this subject is properly the basis of expert testimony at all, or if
it is rather an effort to have a single well-credentialed witness telling the story of the opponent’s bad
documents. That, however, is beyond the scope of this article. See generally Patricia Cohen, History
for Hire in Industry Lawsuits, N.Y. TIMES June 14, 2003 at 7. Also of note, Markowitz has served as
expert witnesses in lead paint litigation as well. See http://www.deceitanddenial.org/purpose/
(noting their involvement in the Rhode Island nuisance lawsuit); see also Eric Tucker, Public Health
Expert Testifies in Lead Paint Case, BOSTON GLOBE Dec. 12, 2005. I am unaware of any comparable
discovery being taken in the lead paint litigation.
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what the industry’s response was to information about
vinyl chloride’s toxicity, and what the industry did with
the information and knowledge that they [sic] acquired.
Specifically, I was asked my opinion of whether the vinyl
chloride industry forthrightly furnished information to
the United States government and its responsible
agencies, whether it forthrightly furnished information to
the public, and whether it forthrightly furnished
information to the people who worked in the vinyl
industry’s plants. It is my opinion that it did not.
The report attached a 251-page chronology that provided substantially more
detail on the actions than the expert report itself did.69 The chronology and report
tracked Deceit and Denial fairly closely, and, based on the discovery sought, the
defendants appear to have anticipated that the fact of Deceit and Denial’s
publication and peer review would be important in the court’s evaluation of
Professor Markowitz’s proffered testimony.70
Attorneys for the defendants sought to take discovery into the process by
which Deceit and Denial was published – in particular into the peer review process.
They served document subpoenas, seeking correspondence and the like, on the
Milbank Memorial Fund and the University of California.71 They also subpoenaed
several participants in the process, including five of the eight actual reviewers,
asking, among other things, how they were selected as reviewers and what the

69

On file with author.
While articles and books may have different processes for peer review, in this instance the
publisher did subject the book to a peer review process, and I assume, I think reasonably, that if the
reviewers had recommended rejection of the book, or recommended changes that the authors
refused, publication would not have gone forward. Regardless of the differences, the issues in taking
discovery into the processes are similar if not identical.
71 See Lane, supra note 61.
70
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review included.72 The specific results of that discovery, whatever they might have
been, are publicly unknown; the case settled in February 2006 and the motions in
limine regarding Markowitz did not address the methodology or otherwise disclose
what was learned.73
We do know that one of the defendants’ experts, history professor Philip
Scranton of Rutgers, opined that (among other things) Markowitz and Rosner acted
unethically in participating in an “open” peer review process (described earlier):
Markowitz . . . admitted that he knew the Milbank
Foundation reviewers for [the book] and had coauthored
publications with some of them. Indeed, not only did
Markowitz join in selecting the manuscript’s referees; he
chose several faculty members from his own institution to
evaluate the draft.
Such practices subverted confidential, objective refereeing
of scholarly manuscripts (single- or double-blind), for this
review was largely done “among friends.”74
The discovery into peer review (and Scranton’s report) received national
attention, including articles in The Chronicle of Higher Education75 and The
Nation.76 Both included suggestions by the experts and others that the discovery
was part of an effort to intimidate or silence industry critics – to scare future
experts off of testifying contrary to the industry’s wishes. In the story, the head of
the university press, Lynne Withey, is quoted as describing the discovery as

72

See id.
On file with author.
74 Report on file with author (citations omitted).
75 See Lila Guterman, Peer Reviewers are Subpoenaed in Cancer Lawsuit Against Chemical
Companies, CHRONICLE OF HIGHER EDUCATION, Nov. 19, 2004 at A20.
76 See supra note 4.
73
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“disturbing” and “pretty sleazy on [the defendants’] part.”77 The historians created
a substantial website presenting similar views, calling the actions “highly unusual,
if unprecedented, intrusions into the academic peer review process.”78
Efforts to obtain discovery from the peer review process are not, in fact,
unprecedented. In one case, a court rejected a “scholar’s privilege” when faced with
discovery into the peer review process.79 Similarly, in the breast implant litigation,
the editor of the New England Journal of Medicine was served with a subpoena
seeking information about the publication of a relevant article.80
According to the motion to exclude testimony based on the study, the
researcher used as the “exposed” population a list of “plaintiffs or potential
plaintiffs” provided to him by the plaintiffs’ attorney, while the “control” group was
recruited from church attendees. The participants were not blinded in any way,
among other potentially problematic methodologies.

The converse can take place as well, with the fact that an expert’s theory
failed the peer review process becoming part of Daubert or other arguments. For
example, in a case involving a purported epidemiological study81 of illnesses near a

77

Guterman, supra note 75. On the other hand, one of the peer reviewers, David Kotelchuck, said
that “apart from having received the subpoena at home at 11:45 p.m. – he does not feel harassed by
it. The industry, he says, ‘wishes to defend itself. . . . It’s perfectly reasonable for them to want to
speak to people who have some information about the evidence,’ he says.” Id.
78 http://www.deceitanddenial.org/purpose/ (last visited Mar. 4, 2006).
79 Solarex Corp. v. Arco Solar, Inc., 121 F.R.D. 163 (C.D.N.Y.1988)
80 Marcia Angell, Science on Trial: The Clash of Medical Evidence and the Law in the Breast Implant
Case 142-146 (1996).
81 According to the motion to exclude testimony based on the study, the researcher used as the
“exposed” population a list of “plaintiffs or potential plaintiffs” provided to him by the plaintiffs’
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Kerr McGee plant, the defendants obtained the comments of peer reviewers who
recommended rejection of the study. Those comments were used to bolster the
defendant’s criticisms of the study:
The Plaintiffs’ Report was rejected by the journal to which
it was submitted. That journal, Occupational and
Environmental Medicine, has provided [Kerr McGee] with
the notes of the reviewers assigned to evaluate the
Report.
One reviewer lodged the same criticisms that [Kerr
McGee] sets out in its motion and brief. Her first note
raises the problem of selection bias, and questions the
“internal validity” of the Report. She then asks whether
researchers and interviewers were blinded to the status of
the study subjects. They were not. She wonders whether
the questionnaires were designed specifically for this
Report. They were not. Continuing, the reviewer points
out that statements in the introduction and discussion
“are not backed up by data in the study.” “This,” she says,
“is not acceptable for publication.” Finally, addressing the
Report’s conclusions, she writes: “The discussion makes
conclusions that are not fully supported by the data. . . .
The poor internal validity of this study does not allow the
final conclusions to be made . . . .”82
I include the full discussion to point out that careful peer reviewers are often
asking precisely the questions that a court applying Daubert should be applying:
-

Is this a sound methodology?

-

Are the conclusions supported by the data?

-

Is it acceptable in the field?

And when peer review is done properly – as it appears to have been in the
Kerr McGee case – it can be a powerful basis for either approval or rejection of the
attorney, while the “control” group was recruited from church attendees. The participants were not
blinded in any way, among other potentially problematic methodologies. Brief on file with author.
82 Brief on file with author (emphasis in original brief; citations omitted).
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methodology in court as well as in publishing decisions, and is appropriately
considered highly useful in determining the reliability of a methodology.83 But
when it is not done well, its status as an indicator for reliability is highly
questionable.
Outside of the peer review process, litigants sometimes seek discovery into
underlying data – for example, data files or interview notes. Such discovery is most
notable when the researcher involved has no connection to the litigation, and is less
directly related to the Daubert process and is more related to an attempt to directly
undercut or re-evaluate the research.84 As I note below, these issues involved in
discovery into matters not directly involving an expert in the litigation at hand
differ.
If the specifics of the peer review in a particular case are potentially relevant
to a court’s evaluation of expert testimony, then why might there be a problem at all
with taking discovery into that process? The details will come later in the Article,
but for now, the core challenge to such discovery is a fear of intimidation and of
chilling participation in the process, and of harm to academic freedom. Whether the
litigants intend it or not, the specter of becoming involved in litigation – which is
undeniably at minimum a hassle and at maximum highly disruptive and expensive
– has the potential to make potential peer reviewers hesitate before agreeing to
83

Sometimes the peer reviewers reject scholarship because the scholar has failed to clearly explain
the results, rather than any flaw with the results themselves. Assuming that the basis for the
rejection is clear, such a rejection should have no impact on the Daubert analysis.
84 See generally Sheila Jasanoff, Research Subpoenas and the Sociology of Knowledge, 59-SUM LAW
& CONTEMP. PROBS. 95 (1996); see also Rebecca Emily Rapp, In re Cusumano and the Undue Burden
of Using the Journalist Privilege as a Model for Protecting Researchers from Discovery, 29 J.L. &
EDUC. 265 (2000) (discussing a First Circuit case, In re Cusumano, 162 F.3d 708 (1st Cir. 1998),
extending the journalist privilege to third-party researchers).
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take part in the process, especially if the litigation removes anonymity that had
previously been promised the reviewers. Further, if it is permitted without
question, litigants may indeed recognize and take the opportunity to chill the
participation of skilled researchers and thus slow the development of science. Any
approach to this issue must at least consider these concerns. Markowitz and Rosner
themselves summarized the concerns well, describing the defendants’ efforts as
“attempts by the chemical industry to shut down discussion of their past and to
interfere with the peer-review process, academic freedom and open debate.”85 They
continue:
Should the peer review process be subject to industrysponsored subpoenas? Should we worry about being
brought in for depositions if we review a ‘controversial’
book? Would we work on controversial subjects at all if
industry lawyers are able to get at our notes, our
documents, and even our colleagues? Would we feel free
to research these topics if we knew that industry can hire
fellow historians to devote months to pick through
footnotes and develop sophistic (not sophisticated)
arguments meant to undermine colleagues’ professional
credibility and integrity? Should we be concerned that
reviewers may decide to avoid participating in the review
process if they know that industry lawyers can later order
them into court proceedings? These are certainly issues
that should be discussed.86
B. You Want Peer Review? We’ll Get Peer Review: Litigation-Driven
Scholarship
85

Gerald Markowtiz & David Rosner, The Chemical Industry’s Attack on Historians, HISTORY NEWS
NETWORK Dec. 6, 2004, available at 2004 WLNR 13455167.
86 Id. In the context of discovery into uninvolved researchers, Jasanoff states that the efforts “may be
motivated by both legitimate and illegitimate considerations.” Jasanoff, supra note 84, at 97.
“Litigants may use the research subpoena to intimidate and overburden researchers or to introduce
irrelevant and confusing issues into the fact-finding process.” Id. But they may also “expect to find
genuine discrepancies between the ‘facts’ reported by scientists and the observations on which their
findings were based.” Id.
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As courts’ consideration of expert testimony becomes more focused on judging
reliability based on the presence or absence of peer review of the methodology,
litigants (and their experts) have seen an opportunity to improve their chances by
obtaining peer review of the methods – often by submitting something very similar
to the litigation expert report to a peer reviewed journal in hopes of getting it
published. Again, some examples may help.
Perhaps the most striking example came in litigation against DuPont
relating to alleged birth defects resulting from fungicide exposure.87 In that case,
the plaintiffs’ attorneys paid for a series of studies, with one of the studies costing at
least $200,000.88 The paid expert “discussed two of the tests with the lead
researcher (his colleague at the same university), provided samples of the fungicide,
and assisted in the design and interpretation of the studies.”89 One study, which
supported the assertions of the paid experts, was published in the peer-reviewed
journal Neurotoxicology without any conflict disclosure (and none, evidently, was
required).90 The other studies were not submitted for publication.91
An example not involving new studies relates to the anti-cholesterol drug
Baycol (cerivastatin), which was voluntarily withdrawn from the market on August
8, 2001 by its manufacturer, Bayer Corporation.92 Over 10,000 lawsuits, most of

87

See Daubert’s Backwash, supra note 57.
See id. at 624 n. 24
89 Id.
90 See id.; see also W.G. McLean et al., The Effect of Benomyl on Neurite Outgrowth in Mouse NB2A
Human SH-SY5Y Neuroblastoma Cells in Vitro, 19 NEUROTOXICOLOGY 629 (1998).
91 See Daubert’s Backwash at 624. As of the date of Daubert’s Backwash, the plaintiffs’ expert had
been excluded in at least two matters. See id.
92 See FDA, Bayer Voluntarily Withdraws Baycol,
http://www.fda.gov/bbs/topics/ANSWERS/2001/ANS01095.html (last visited March 12, 2006). In
88
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them alleging various muscle injuries, were eventually filed, with the federal multidistrict litigation eventually reaching the third-largest federal multi-district
litigation to date. As has become comm
on in mass tort litigation, attorneys for both
sides retained experts in many areas, including the obvious subjects of general and
specific causation, but also subjects such as medical and corporate ethics, with
experts opining on the appropriateness of the company’s actions based on
knowledge at various times.
The first two trials, both in early 2003, ended in defense verdicts. Later,
three paid experts retained by plaintiffs’ attorneys in the litigation published an
article in the Journal of the American Medical Association discussing Bayer’s
actions in connection with the medication. The article largely tracked the opinions
given as paid expert witnesses by the authors and disclosed their role as plaintiffs’
experts while stating that the article was based only on public information.93 To
date, those authors have not appeared in any Baycol trials, though they have been
designated as experts since then.
The Kerr McGee case cited above is, perhaps the most typical case of
litigation-driven scholarship.94 The report in question there was clearly created in
connection with litigation – indeed, the “exposed” population was identified by the
private practice, I worked as one of Bayer’s attorneys in the Baycol litigation and continue to do a
minimal amount of consulting work in the litigation.
93 Psaty et al., Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug
Reactions, JAMA (Dec. 1, 2004). In the same issue, Bayer’s response (authored by Joseph D.
Piorkowski, D.O., J.D., M.P.H., who served as Bayer’s counsel) to Psaty et al. was published, an
alternative view authored by Dr. Brian L. Strom, M.D., M.P.H. of the University of Pennsylvania
(who had served as an expert witness for Bayer), as was a JAMA editorial on the subject and a reply
from Psaty et al. All authors’ involvement as counsel or experts was disclosed. See JAMA (Dec. 2,
2004).
94 See supra note 82 and accompanying text.
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plaintiffs’ firm itself, obviously creating enormous potential for selection bias. If not
for the fact of the retention of the experts, those studies would almost certainly not
have occurred.
Litigation-driven scholarship is not, to be sure, limited to plaintiffs’-side
experts. A 1992 Ohio asbestos case discussed the admissibility of an article written
by one of the defendant’s experts:
The article was written by defendant’s expert, Dr. Corn,
with fifteen other scientists. Dr. Corn compiled and
analyzed air sampling tests conducted in seventy-one
school buildings across the country which contained
asbestos materials. The expert concluded that the levels
of asbestos fibers in the air inside the schools were not
higher than the levels in air outside the schools, and,
therefore no incremental health risk from asbestos existed
in these buildings. The article was submitted for peer
review before publication in the scientific journal
[Regulatory Toxicology and Pharmacology].95
The expert acknowledged that the data he used came from other court cases in
which he was involved as an expert, but stated that he prepared the article as a
researcher, not as an expert witness.96 The court admitted the testimony.97
This incentive to create scholarship may result in the publication of whole
new areas of purported expertise that have not previously been published and that
may not genuinely be properly the subject of expert testimony – scientists opining

95

Worthington City Schools v. Abco Insulation, 616 N.E.2d 550, 553 (Ohio. Ct. App. 1992).
See id.
97 See id.
96
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about the ethics of defendants, for example.98 The potential for bias is, of course,
obvious:
[T]he reliability and accuracy of litigation-based research
is likely to be viewed with suspicion because of the
potential bias arising from the source of funding for the
research and the relationship between the researchers
and the lawyers. Pressures resulting from the need to
have the “right” outcome may result in manipulated
procedures, distorted data, selective reporting of results,
or even falsified outcomes.99
It is no surprise, given the incentives created by Daubert and the Rules’
implementation of Daubert, that litigation-driven scholarship has developed.100 Nor
is it surprising, as noted earlier, that discovery into peer review is perhaps on the
upswing. In the next Part, I consider whether either of these developments is
necessarily problematic.
IV. How Science and Law Can Strengthen Each Other
Expert witnesses are allowed to testify if they are able to, among other
things, “assist the trier of fact to understand the evidence or to determine a fact in

98

The propriety of this sort of expert is beyond the scope of this Article. Briefly, though: my basic
concern with such testimony is not Daubert-related as such, but instead has to do with whether the
testimony aids the jury. Thus, for example, I certainly can see the value of an attorney hiring a
historian to prepare a chronology of documents and events that supports a particular interpretation
of the facts of a case. But once that chronology is completed, I believe a jury can ordinarily reach the
conclusions on its own, and that presenting a purported expert to tell the story is potentially
improperly placing what should be an attorney’s closing argument in the middle of the trial.
99 Anderson et al., supra note 57, at 621.
100 Indeed, the Ninth Circuit (prior to the Supreme Court Daubert decision) noted that a lack of peer
review is often a problem with litigation-driven scholarship. See Daubert v. Merrell Dow
Pharmaceuticals, 951 F.2d 1128, 1131 (9th Cir. 1991) (“Scientific studies conducted in anticipation of
litigation must be scrutinized much more carefully than studies conducted in the normal course of
scientific inquiry. This added dose of skepticism is warranted, in part, because studies generated
especially for use in litigation are less likely to have been exposed to the normal peer review process,
which is one of the hallmarks of reliable scientific investigation.”).
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issue.”101 The goal of their testimony, therefore, must be to explain why a disputed
allegation is either more or less likely to be true. In order to evaluate any
testimony, a court or jury considers the basis of the testimony – the data on which it
is based, to put it another way – and the reasonableness of the witness’s
conclusions.
This process – questioning the premises, the methods, the reasonableness –
tracks the process used in evaluating scientific research.102 The post-publication
evaluation of research, whether by replicating it or building on it, is a critical part of
the progress of science.103 Indeed, this post-publication evaluation is probably more
important than the publication peer review that courts (and this Article) focus on.
Such searching examination of research is highly effective at eventually
ferreting out bad research, and that conclusion is the premise of two key
conclusions: First, science and law have numerous checks already in place to catch
bad research, and so courts need not automatically reject litigation-driven
scholarship. Second, those same checks are strengthened and complemented,
especially in the context of litigation-driven scholarship, by permitting discovery
into the peer review process. I address each in turn.
A.

Why Courts Should Not Exclude All Litigation-Driven

Scholarship

101

F.R. Evid. 702.
See supra part II. I do not suggest that the litigation process and its adversarial nature are the
same as peer review, only that there is substantial overlap. Cf. Sheila Jasanoff, SCIENCE AT THE
BAR: LAW, SCIENCE, AND TECHNOLOGY IN AMERICA (Harvard University Press 1995) 8 ("[T]he
cultures of law and science are in fact mutually constitutive in ways that have previously escaped
systematic analysis....[T]hese institutions jointly produce our social and scientific knowledge...."),
103 See Daubert’s Backwash, supra note 87, at 628-29.
102
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For the same reason that judges instruct juries that they are entitled to
consider the financial interest of a witness in determining the witness’s credibility,
the fact that a particular item of research was performed and published by a paid
litigation witness (whether paid by the plaintiff or defendant) is, of course, relevant
to consideration of its credibility. The source of the funding is relevant just as the
funding of clinical trials by pharmaceutical companies is relevant to the evaluation
of those studies – because the funding of research demonstrably can affect its
outcomes.104
To put it mildly, such bias likely exists in work performed by experts in
litigation; it is highly unusual for a party’s retained expert to testify contrary to the
party’s litigation position. Though experts are generally precluded from working for
contingent fee,105 attorneys undoubtedly consider their success in obtaining verdicts
in their favor in deciding whether to re-hire experts, so – even when publishing an
article nominally separate from their litigation work – the authors of litigationdriven (or even merely litigation-related) scholarship do have a financial interest in
the outcome of the research. The conflict of interest is at least as real as in the
context where research is funded by, for example, a pharmaceutical company.
An additional reason to be skeptical of litigation-driven scholarship arises
from the timelines of scientists as compared the timelines of lawyers. Science (and
academic research more generally) tends to be incremental, where it can take years

104

See generally NEJM, Sponsorship, Authorship, and Accountability, available at
http://content.nejm.org/cgi/content/full/345/11/825
105 See, e.g., Comment to ABA Model Rule 3.4(b) (“The common law rule in most jurisdictions is that
it is improper to . . . pay an expert witness a contingent fee.”).
39 of 57

Childs • Overlapping Magisteria

to develop a body of research that addresses a hypothesis.106 The ongoing review of
conclusions by colleagues and competitors takes time, as theories are considered,
tested, and discarded, revised, or confirmed. Litigation necessarily moves faster:
statutes of limitations run; witnesses forget, move, or die; plaintiffs want a recovery;
defendants want a resolution; attorneys want their fees, whether hourly or
contingent. In most lawsuits, the expert’s opinion (and thus, if relevant here, the
litigation-driven research) is a one-time event, with at most minor changes as the
case progresses. Even if the work receives publication peer review, it may not
receive the ongoing review of peers (at least during the relevant litigation time
period), and so it has not been genuinely tested.107
Further, litigants demand firm conclusions and an expert’s commitment to
those conclusions. For a testifying expert, “probably” is not a good answer very
often. In contrast, the incremental nature of much scientific research requires
hints, false starts, ideas that fail, and good guesses all along the process.
That said, just as medical journals and courts do not automatically reject
studies paid for by drug sponsors or reject the first study in a particular area, the
fact that research is done in the context of litigation does not mean it should
automatically be excluded, either from journals or evidence in trial. Rule 702,
indeed, provides that the litigation origin of research should be considered a factor,
but only a factor, in evaluating expert testimony.108 Many questions of interest to

106

See Daubert’s Backwash, supra note 57, at 630-31.
See Daubert’s Backwash, supra note 87 at 630-31 (discussing the disjunction between litigation’s
timeline and the incremental steps of developing science).
108 Fed. R. Evid. 702.
107
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public health (or other important policies) may only be evaluated in the context of
litigation. In cases where a product has been withdrawn or recalled, for example,
there is no well-funded group other than attorneys who have an interest in learning
more about the product. If paid litigation experts do not perform certain research,
then, it may well not be done at all – and the financial interest in the outcome is not
significantly different for attorneys than for sponsoring companies paying for
studies of their products. This is likely the most obvious in mass tort litigation,
where nobody besides attorneys has any incentive to fund ongoing research into
withdrawn products – but that research may provide useful information for future
products, and those attorneys can have hundreds of thousands of dollars available
for performing the research, whether it is original research or a post-hoc evaluation
of a combination of clinical trials.109
Put briefly: We trust scholarly journals, and juries, to be able to evaluate the
weight that should be given to the bias in financial support in other contexts. That
trust should extend to judges’ abilities to evaluate the reliability of methodology in a
Daubert analysis – at least enough to identify bias as one factor rather than a per se
basis for exclusion. One can quite reasonably argue that we ought not be asking
juries (or even judges) to be evaluating science at all; such an argument counsels in
favor of systems of health courts and the like. But if judges and juries are to be
evaluating science at all, they will be considering scholarship with the potential of

109

See supra note 88 and accompanying text (discussing a case in which plaintiffs’ attorneys spent
$200,000 on a single study).
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bias, and we ought to trust them to consider that bias as well as they consider other
biases.
Additionally, serious scholars have substantial reasons to self-regulate to
avoid the scorn of colleagues or, perhaps more problematic, a published court
decision declaring them unreliable or dishonest.110 Reputation is, in many respects,
the coin of the realm in academia, though in some cases that coin may well be
traded for the more literal coin of retention as a paid expert. While it obviously is
not a panacea, danger to reputation (a danger that may threaten future expert
retentions) helps balance the risks of accepting litigation-driven scholarship.111
Finally, the availability of discovery into the peer review process itself
(discussed in the next section) helps mitigate the potential harm of litigation-driven
scholarship. Attorneys can learn about numerous subjects potentially relevant to
the Daubert decision (and to the fact-finder’s evaluation of the expert’s credibility):
•

What was the nature of the peer review? (Anonymous, open, one
reviewer, expertise of reviewer)

•

How long did the reviewers take to review the piece?

•

Did the reviewers know that the authors had a financial interest in the
outcome?

•

Did the reviewers or editors have a financial interest in the outcome of
the litigation?

110

I understand, for example, that the expert whose testimony was rejected in the Daubert decision
itself has reappeared in later litigation with similar methodologies.
111 In the Conclusion, I discuss one further potential check on litigation-driven scholarship, that of
requiring the disclosure in the work itself of both the fact of and the extent of the financial payments
received from counsel.
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•

Were the reviewers acquainted or friendly with the author?

•

Did the author exploit personal connections with the editors or
reviewers?

•

Is the journal or publisher involved well-regarded?

•

Do they have an interest in the outcome of the litigation?

Thus, especially with liberal discovery available to litigants to fully develop
the potential biases or other problems with the research, litigation-driven
scholarship should not be rejected strictly because it comes out of litigation. That
fact does not sufficiently distinguish it from other scholarship that is published and
admitted daily in reputable journals and in courts.
B.

Why to allow discovery into peer review

The potential value of litigation-driven scholarship is not terribly
controversial; after all, most of the examples cited above were published, some in
prestigious journals. The practice of litigants taking discovery into the peer review
process, however, appears more broadly disturbing. In this subpart, I argue that
the concerns attributed to such discovery, while relevant, should not bar the
practice. Taking discovery into peer review offers an opportunity for litigants and
courts to better evaluate the resulting scholarship and to know how much weight to
put on the fact of peer review. Additionally, this discovery process has the salutary
effect of educating judges about the realities of peer review, discussed above, giving
them a better foundation forDaubert and related decisions. I address the reasons
in three sections.
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1.

The possibility of subpoenas and depositions helps counter bad

litigation-driven scholarship.
As noted above, the availability of discovery into the peer review process can
provide real assistance in balancing the realities of litigation-driven scholarship.
The adversarial system is not unique to law; it is in fact a critical part of science,
and adding to it can strengthen it. As Nobel Laureate in Medicine George von
Bekessy put it:
[One] way of dealing with errors is to have friends who
are willing to spend the time necessary to carry out a
critical examination of the experimental design
beforehand and the results after the experiments have
been completed. An even better way is to have an enemy.
An enemy is willing to devote a vast amount of time and
brain power to ferreting out errors both large and small,
and this without any compensation. The trouble is that
really capable enemies are scarce; most of them are only
ordinary. Another trouble with enemies is that they
sometimes develop into friends and lose a good deal of
their zeal. It was in this way the writer lost his three best
enemies. Everyone, not just scientists, need a few good
enemies!112
Except for the absence of compensation, someone who “is willing to devote a
vast amount of time and brain power to ferreting out errors both large and small”
sounds a lot like a devoted attorney preparing for a cross-examination. But
attorneys can do even more than even “really capable enemies” in the sciences can

112

Von Bekessy’s statement, originally at G. V. Bekessy, Experiments in Hearing (McGraw Hill, New
York 1960) at 8, is quoted in George A. Olah’s Nobel Lecture in 1994. See George A. Olah, Nobel
Lecture, My Search for Carbocations and Their Role in Chemistry, available at
http://nobelprize.org/chemistry/laureates/1994/olah-lecture.pdf (last visited March 12, 2006). This
“enemy” concept likely has particular strength in the context of dramatic changes in a field, such as
Crick and Watson’s paper. If their assertions had been disproved, their careers would have been at
least seriously injured, if not ended.
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do – lawyers can compel document production and testimony and find not just large
and small errors, but flaws in the publication process itself.
Consider: How often would a competing researcher challenge the method
used in peer review? How often would a competing research demand access to the
underlying research, to the extent of wanting to (and being allowed to) re-interview
subjects of a study? How often could they demand an opportunity to spend hours
asking the peer reviewer about the review? And obtain copies of the comments of
the reviewers? How often could they bring the court's power of subpoena to bear?
How often would they have the money available to do those interviews and hire a
consulting expert to painstakingly evaluate the work? The answer, of course, is
“virtually never” to every one of the questions. Science already is utterly reliant on
an adversarial system; allowing lawyers into it is an extension and expansion of the
same. It may be uncomfortable, but it is not new.
Sheila Jasanoff, writing in the context of subpoenas to researchers who do
not have a connection to the litigation in issue, disputes the ability of courts “to
distinguish between valid and invalid scientific claims,” arguing that the
expectation rests on “questionable assumptions about the practice of science.”113
Those assumptions:
•
•

113

that evidence of fraud, error, and poor scientific
practice can be detected unambiguously from written
records;
that challenged methodologies (including methods of
analysis and interpretation) clearly conform or do not
conform to “scientific” standards;

Jasanoff, supra note 84, at 97.
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•
•

that such standards preexist and hence can be
mechanically applied during legal inquiry; and
that the adversarial process is conducive to sorting out
disputes concerning the validity and reliability of
competing research practices.114

Jasanoff argues that those assumptions are inconsistent with if not contradicted by
modern thought about the sociology of science.115
While this argument does counsel in favor of caution when allowing wideranging discovery into non-party research, in fact it supports the availability of
certain peer review discovery – because it will permit litigants to explore the very
ambiguities in science that Jasanoff identifies, and because it will assist in
educating the courts about the limitations of science. Those courts may well still
make declarations that suggest an excessive focus on certainty, but the more they
learn about the scientific process, the more that claimed certainty will be a useful
fiction rather than a genuine reflection of judges oversimplifying. Put another way:
A necessary assumption of practicing law is that a fact can be established, while a
foundation of science is that all purported facts can be challenged. Courts that
expect final answers from science are being unrealistic, and opening the black box of
peer review will help reveal the reality while permitting courts to do a better job of
reaching final legal answers. Thus, rather than using a lack of understanding of
science to suggest that litigants and courts should stay out of it, we should recognize
peer review discovery as a way to improve that understanding.

114
115

Id. at 97.
See generally id.
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2.

The possibility of subpoenas and depositions provides incentives to do

the research, and the peer review, correctly.
Researchers quite reasonably lament the possibility of being deposed.116
Depositions are unpleasant experiences, presumably even more so when being done
with the aim of undercutting the validity of one’s scholarly work. But having to face
that possibility may create additional incentives to strive for better research and
better peer review. Peer reviewers, properly, do not generally examine the
underlying documents, data, and so on, on which scholarly research is based, and so
researchers may feel somewhat safe in using fudged data. When the stakes are
sufficiently high, cross-examining attorneys do exactly what peer reviewers do not
(as well as what they do).
Having such detailed scrutiny as even a remote possibility may decrease the
likelihood of scholars using any sleight of hand. And that possibility becomes ever
more remote when the research is genuinely above reproach. Similarly, if the peer
review process is demonstrably solid – demonstrable through correspondence and

116

See Wiener, supra note 4 (“Academics aren't used to being ‘commanded’ to do anything, and are
unlikely to have attorneys of their own to accompany them to depositions.”). In describing the
depositions involved in Deceit and Denial, Wiener writes:
Cook's deposition took only an hour, but it was "an hour of battering and
legal tricks, and the goal was to trip you up and get you confused," she said.
"They kept asking me how long I had known Gerry Markowitz. I said, 'Are
you asking if I had an affair?' They said, 'No, why are you asking that?' I said,
'Where I come from, that's the implication of your question.' They said,
'Where do you come from?'"
Id.
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notes, which can be produced with relatively little difficulty – the likelihood of a
deposition shrinks, as there is little potential value.117
This point remains applicable whether or not the research in question is
litigation-driven, or in fact whether or not the expert witness was involved in the
research in question. If the expert is relying on peer-reviewed research that he did
not perform, the opponents of the expert’s testimony may well have a legitimate
reason to explore the validity of that research, though, as I note below, the burden
to show the propriety of the discovery may well be greater.
3.

Discovery into the peer review process opens the black box of peer review

and educates the courts.
Some commentators have looked at the 20+ years of experience with Daubert
and concluded that the shift in focus has had relatively minor effects on the outcome
of cases, but, importantly, that it has educated judges about the realities of
science.118 By providing judges factors to consider, the argument goes, the judges
will learn more about how those factors relate to reliability and how scientists think
about the issues. Similarly, allowing discovery into peer review processes will
inform judges about the realities of those processes, and the many forms that those
processes take, as described above.119

117

This point may be moderately naïve. From experience, I am aware that many depositions are
taken without any real hope of getting something useful. The percentage that fit that description
rises as the stakes rise. As noted infra, I do have some suggestions to deter fishing expeditions,
including the possibility of a judge appointing an expert to evaluate the request to take discovery
into the peer review process.
118 [Cheng & Yoon].
119 See supra note Error! Bookmark not defined..
48 of 57

Childs • Overlapping Magisteria

In lay press coverage of the Deceit and Denial depositions, the reviewers and
others focused on the perceived oddity of the attorneys asking the reviewers if they
had checked all of the footnotes.120 This focus misses the point. The point of the
questions was almost certainly not to show that the reviewers failed in their job, but
rather to point out the limitations of that job and thus of the endorsement, as
suggested earlier. If the defendants could later show that those footnotes were not,
in fact, accurate, then the reviewers’ recommendation of publication could
reasonably be called into question, not necessarily because they did not do their job,
but because facts on which they (reasonably) relied were inaccurate. By so showing,
too, the courts involved would learn more about what peer reviewers actually do.
We have already seen that some judges have an oversimplified view of the
realities of peer review. Through allowing discovery into peer review, judges will
learn through seeing the outcome of that discovery that peer review is not binary,
but instead a spectrum, and will be better able to evaluate scholarship that is
provided to them as peer reviewed, and better able to determine its reliability and
admissibility.
V.

Proposals and Conclusion

The reasons I have suggested for developing a level of comfort with discovery
into the peer review process and with litigation-driven scholarship are all related,
and they relate to the goals of Daubert in the first place – a recognition that law and
science, while having substantial differences, have overlapping magisteria. “The
120

See id. (“The prevailing practice at university presses is that manuscript reviewers are not
expected to check footnotes; Lynne Withey, director of the University of California Press, asked,
‘How could you expect people to do that?’”).
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net of science covers the empirical universe: what is it made of (fact) and why does
it work this way (theory).”121 Similarly, law – as it relates to expert testimony – has
to do with facts (what the expert tells the factfinder jury it should conclude) and
theory (why the jury should do so). The relevant criteria for evaluating those
asserted facts and theories should largely line up.
Scientists welcome challenges from sources within their magisterium,
whether by way of competing publications, challenges in the peer review process,
revisions in the publication process, or otherwise. They should not automatically
reject similar challenges from an overlapping magisterium – law – simply because
they come from outside their home turf.
Of course, the complaints about discovery into peer review are not baseless.
Depositions are unpleasant and expensive, complying with document requests is
expensive, and lawyers are largely not scientists’ favorite companions (and are, too,
expensive).122 Between the inconvenience and expense, the availability of such
discovery may be a disincentive to participate in peer review – especially given the
fact that most peer review is done as a professional obligation rather than for pay.
Before addressing some ways to mitigate that disincentive, a reality check
may help. Even if peer review discovery becomes much more widely adopted,
depositions and document discovery will almost certainly take place in a very small
percentage of instances of peer review. Most scientific scholarship is simply not

121
122

Steven Jay Gould, supra note 6.
See generally Wiener, supra note 4.
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that interesting to litigators, just like most legal scholarship is not that interesting
to scientists (or, sadly, others!).
Thus, the universe of cases in which litigation is even on the horizon is small
– and that universe is likely identifiable in advance (e.g., articles about drugs,
devices, toxic effects of industries, and a handful of other items, plus perhaps some
patent-related scholarship). If a publisher chose not to accept for publication what I
have described as litigation-driven scholarship,123 whether to avoid hassle or
because it concluded that the inherent biases militated against such scholarship,
the universe would get still smaller.
Alternatively, a journal could switch to an open peer review process, with the
reviewers’ comments and identities open to anyone, similarly reducing discovery
exposure.124 Such a switch would reduce both the likelihood and extent (and thus
burden) of peer review discovery.
Journals also should require the disclosure of litigation relationships. By
their terms, at least some journals’ disclosure policies do not require such disclosure
at all.125 In contrast, the Federal Rules of Civil Procedure require expert witnesses

123

Though I think that litigation-driven scholarship is not inherently untrustworthy, a journal could
rationally conclude otherwise, just as some have refused to accept articles funded by industry. If
anything, I think litigation-driven scholarship is less trustworthy than industry-funded work (as the
intended outcome is explicit in the former and less so in the latter), and so a policy rejecting
litigation-driven work but accepting industry-funded work could be consistent.
124 See supra note 46 and accompanying text.
125 See NEJM, Financial Associations of Authors, http://content.nejm.org/cgi/content/full/346/24/1901
(“Because the essence of reviews and editorials is selection and interpretation of the literature, the
Journal expects that authors of such articles will not have any significant financial interest in a
company (or its competitor) that makes a product discussed in the article.”). “Significant” is defined
in that article as $10,000 or more in a year; insignificant interests are to be disclosed in the article.
Notably, the policy makes no mention of involvement in litigation.
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to disclose the compensation to be paid for their testimony.126 In at least those
cases involving litigation-driven scholarship, authors should be obligated to disclose
not just the fact of their litigation work but also, at minimum, an estimate of the
payments received. In an era of expert witnesses on all sides being paid up to $500
or more an hour for work and testimony, consumers of that scholarship should
receive at least the same information that a jury would receive.127
Further, the number of individual cases that would go beyond document
discovery to depositions is even smaller, because, if the documents indicate
thorough and unbiased review, the attorneys are likely to conclude that a deposition
is not worth it. The litigation and hassle exposure, in other words, would be small
even if those involved in the peer review process had no protection beyond the
ordinary protections in third-party discovery. This simply does not happen that
often and is unlikely to have a significant increase in frequency.128
And yet there is legitimate concern, and so some ways to mitigate the risks
may be valuable, both in the publication process and in the courts. As for reviewers
and publishers, in those cases where litigation seems possible (or in all cases, to
better spread costs), peer reviewers could demand that the publishers indemnify
them for expenses associated with discovery, including the cost of counsel and the

126

FED. R. CIV. P. 26(A)(2)(b).
Such information may well be valuable information in work that is not litigation-driven as well.
128 A further reality check: While discovery into peer review is relatively new, research subpoenas
have been around for at least a decade. See Jasanoff, supra note 84. I am aware of no evidence, even
anecdotal, that any researchers or reviewers have in fact been deterred from getting involved in
potentially litigation-related research. The absence of declarations about it is not proof of its actual
absence, of course, but it is worth noting.
127
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reviewers’ time.129 (Often, of course, the parties to litigation end up paying for the
time of deponents, especially if the deponent is outside the scope of the subpoena
power.) The additional costs to the publisher will be minimal at most, especially if
its peer review process is solid and well-documented (which is a good thing to
encourage in all events). The financial impact on the availability of qualified peer
reviewers should, then, be minimal, with those costs able to be spread by the
publisher.
Yet the discovery does create dangers not created by the average discovery
process, and concerns about academic freedom and disincentives are not baseless. I
therefore propose certain protections that balance those legitimate concerns against
the litigants’ legitimate interests in testing assertions.
When a party seeks discovery into research performed by a testifying expert
and cited or relied upon by that expert – in other words, the party seeks drafts of
the work, reviewers’ comments in the expert’s possession, editorial suggestions, and
the like – that discovery should be granted as a matter of course under the ordinary
discovery protections.130 Thus, if a party’s discovery is not calculated to lead to the
discovery of relevant materials, it can properly be quashed, but no special protection

129

In fact, the University of California press paid for the reviewers’ legal fees in the depositions
related to Deceit and Denial. See Wiener, supra note 4.
130 See, e.g., F.R.Civ.P. 26(b)(1): “Parties may obtain discovery regarding any matter, not privileged,
that is relevant to the claim or defense of any party, including the existence, description, nature,
custody, condition, and location of any books, documents, or other tangible things and the identity
and location of persons having knowledge of any discoverable matter. For good cause, the court may
order discovery of any matter relevant to the subject matter involved in the action. Relevant
information need not be admissible at the trial if the discovery appears reasonably calculated to lead
to the discovery of admissible evidence.”
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is necessary. The expert has, after all, submitted himself to the process voluntarily
and the courts’ general protections against harassment are sufficient.
When the party seeks to go further and take discovery into the peer review
process, at least two steps should be followed. Limited document discovery,
including document subpoenas, limited interrogatories, and similar methods, should
be permitted, again under the same processes used for ordinary third-party
discovery. The potential for intimidation and inconvenience is relatively small in
this context and can be mitigated, as noted above, through indemnification
agreements. The identities of the peer reviewers, if previously anonymous, could be
redacted at this stage in the process as well.
If, upon the completion of this limited document discovery, the party wishes
to take the depositions of individuals not involved directly in the litigation or to take
further document discovery, including seeking the names of the reviewers, the court
should require a showing that the party has a reasonable basis to suspect that such
discovery will be valuable. Such a showing might include a showing that the
reviewer was not informed about the fact that the author was paid by attorneys
involved in the litigation (if the scholarship is litigation-related), an indication to
suspect that the reviewer was either lax or not disintereted, or other arguments
that the process did not work as expected, such that the court should discount or
disregard the peer review factor under Daubert. In the event that the party
opposing discovery can show a need, courts could use protective orders to maintain
the anonymity of the reviewers, at least for the time being.
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As part of this evaluative process, a court may find it beneficial to have an
expert who works for the court.131 The expert could be chosen by agreement of the
parties, with the party seeking discovery responsible for his fees, and would be
there essentially as a reality check for the judge. Thus, the expert might be a
researcher from a local university who could provide some perspective on whether
the peer review process in question deviated significantly from the ordinary process
and whether a deposition was likely to provide something useful, rather than being
harassment.
Daubert and the Rules of Evidence have, commendably, sought to incorporate
more of the reliability criteria from science into courts’ evaluation of expert
testimony. This incorporation recognizes the overlapping magisteria of law and
science. Law and science alike rely on testing and challenges to pursue reliable
evidence-based conclusions. While the respective disciplines obviously have many
differences, the bases on which they reach conclusions about the reliability of
methodologies and conclusions are strikingly similar.
These similarities have, as described above, led to both litigation-driven
scholarship and to efforts to take discovery into the process of obtaining publication
in scientific literature, in particular the peer review process. These two phenomena
should not be surprising in light of Daubert and, as I have argued above, should not
be rejected as necessarily negative for either law or science.

131

Cf. William Schulz, Judging Science, CHEM. & ENG. NEWS (Feb. 27, 2006) (noting proposals for
court-appointed experts).
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Litigation-driven scholarship, while subject to many caveats, is not
necessarily any less trustworthy than scholarship driven by those who fund it,
whether that means pharmaceutical companies, government agencies, or
universities spending discretionary grant money. The source of funding for studies,
and the reasons for doing those studies in the first place, are all considered relevant
but not dispositive in other contexts. No reason exists to treat the litigation relation
of scholarship differently.
Discovery into peer review has the potential to strengthen both law and
science. As for strengthening law, judges will better understand the peer review
process once they have seen the results of this discovery, and will understand the
truly complex and varied activities that all fall within the umbrella term “peer
review.” More importantly, the information received through that discovery is
directly relevant to the Daubert evaluation and will better filter expert testimony.
As for what science gets out of it, the possibility, even remote, of litigation discovery
will creative incentives for authors and reviewers to be careful, especially when they
are authoring or reviewing litigation-driven scholarship (where such discovery is
most likely).
Allowing for the cross-fertilization of law and science in this context, then,
will help both and, if appropriate protective measures are used, will hurt neither.
As in all aspects of litigation, courts must be vigilant to avoid harassment or
intimidation, especially with the additional concerns of academic freedom. But
those concerns are not so great as to justify denying access to highly relevant
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materials. Similarly, concerns about the biases inherent in litigation-driven
scholarship are not so great as to justify ignoring potentially important scholarship.
With proper care, the overlapping magisteria of law and science can provide
additional support for each other.
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